CVKDCadrenal Therapeutics, Inc.
- Market cap
- $2.97M
- as of 2026-10-23
- Latest close
- $0.96
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-06
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Pham Quang XChairman and CEO | Oct 9 | Oct 13 | A · derivative | 200,000 | $0.91 | $182,000 | 200,000 | No | Form 4 |
| Golden Lee Scott | Oct 9 | Oct 13 | A · derivative | 75,000 | $0.91 | $68,250 | 75,000 | No | Form 4 |
| Murphy John Raymond | Oct 9 | Oct 13 | A · derivative | 75,000 | $0.91 | $68,250 | 75,000 | No | Form 4 |
| Cole Jeffrey ScottChief Operating Officer | Oct 9 | Oct 13 | A · derivative | 150,000 | $0.91 | $136,500 | 150,000 | No | Form 4 |
| Wilson Glynn | Oct 9 | Oct 13 | A · derivative | 75,000 | $0.91 | $68,250 | 75,000 | No | Form 4 |
| Pham Quang XChairman and CEO | Jun 29 | Jul 1 | S | 7,400 | $3.03 | Sale −$22,422 | 98,589 | Yes | Form 4 |
| Pham Quang XChairman, CEO and Interim CFO | Jun 26 | Jun 26 | S | 9,029 | $3.05 | Sale −$27,538 | 105,989 | Yes | Form 4 |
| Pham Quang XChairman, CEO and Interim CFO | Jun 25 | Jun 26 | S | 2,127 | $3.00 | Sale −$6,381 | 115,018 | Yes | Form 4 |
| Pham Quang XChairman, CEO and Interim CFO | Jun 23 | Jun 24 | S | 2,277 | $3.20 | Sale −$7,286 | 117,145 | Yes | Form 4 |
| Pham Quang XChairman, CEO and Interim CFO | Jun 22 | Jun 24 | S | 9,167 | $3.55 | Sale −$32,543 | 119,422 | Yes | Form 4 |
| Pham Quang XChairman, CEO and Interim CFO | Jun 17 | Jun 18 | S | 513 | $3.16 | Sale −$1,621 | 128,589 | Yes | Form 4 |
| Pham Quang XChairman, CEO and Interim CFO | Jun 16 | Jun 18 | S | 3,613 | $3.18 | Sale −$11,489 | 129,102 | Yes | Form 4 |
| Pham Quang XChairman, CEO and Interim CFO | Jun 15 | Jun 15 | S | 3,666 | $3.58 | Sale −$13,124 | 132,715 | No | Form 4 |
| Pham Quang XChairman, CEO and Interim CFO | Jun 12 | Jun 15 | S | 12,996 | $3.94 | Sale −$51,204 | 136,381 | No | Form 4 |
| Pham Quang XChairman, CEO and Interim CFO | Jun 11 | Jun 15 | S | 1,462 | $4.12 | Sale −$6,023 | 149,377 | No | Form 4 |
| Pham Quang XChairman, CEO and Interim CFO | Jun 10 | Jun 10 | S | 3,500 | $4.21 | Sale −$14,735 | 150,839 | Yes | Form 4 |
| Pham Quang XChairman, CEO and Interim CFO | Jun 9 | Jun 10 | S | 12,992 | $4.06 | Sale −$52,748 | 154,339 | Yes | Form 4 |
| Pham Quang XChairman, CEO and Interim CFO | Jun 8 | Jun 10 | S | 5,893 | $4.38 | Sale −$25,811 | 167,331 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Jun 5 | Jun 5 | S | 2,064 | $4.42 | Sale −$9,123 | 173,224 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Jun 4 | Jun 5 | S | 3,898 | $4.41 | Sale −$17,190 | 175,288 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Jun 3 | Jun 5 | S | 2,323 | $4.26 | Sale −$9,896 | 179,186 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Jun 2 | Jun 2 | S | 349 | $4.46 | Sale −$1,557 | 181,509 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | May 29 | Jun 2 | S | 303 | $5.01 | Sale −$1,518 | 181,858 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | May 28 | May 29 | S | 2,989 | $4.93 | Sale −$14,736 | 182,161 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | May 12 | May 29 | S | 3,298 | $5.28 | Sale −$17,413 | 185,150 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | May 11 | May 29 | S | 6,476 | $5.76 | Sale −$37,302 | 188,448 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | May 22 | May 26 | S | 1,165 | $5.69 | Sale −$6,629 | 194,924 | Yes | Form 4 |
| Szot Matthew KChief Financial Officer | Dec 29, 2025 | Dec 31, 2025 | S | 9,933 | $6.97 | Sale −$69,233 | not reported | Yes | Form 4 |
| Golden Lee Scott | Dec 2, 2025 | Dec 3, 2025 | A · derivative | 5,000 | $8.27 | $41,350 | 5,000 | No | Form 4 |
| Pham Quang XCEO and Chairman | Oct 27, 2025 | Oct 28, 2025 | S | 1,315 | $13.99 | Sale −$18,397 | 196,089 | Yes | Form 4 |
| Szot Matthew KChief Financial Officer | Oct 27, 2025 | Oct 28, 2025 | S | 1,800 | $13.99 | Sale −$25,182 | 9,933 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Oct 24, 2025 | Oct 28, 2025 | S | 1,129 | $14.03 | Sale −$15,840 | 197,404 | Yes | Form 4 |
| Szot Matthew KChief Financial Officer | Oct 24, 2025 | Oct 28, 2025 | S | 1,800 | $13.99 | Sale −$25,182 | 11,733 | Yes | Form 4 |
| Szot Matthew KChief Financial Officer | Oct 13, 2025 | Oct 14, 2025 | S | 1,800 | $14.07 | Sale −$25,326 | 13,533 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Oct 13, 2025 | Oct 14, 2025 | S | 1,800 | $14.15 | Sale −$25,470 | 198,533 | Yes | Form 4 |
| Szot Matthew KChief Financial Officer | Oct 9, 2025 | Oct 14, 2025 | S | 1,693 | $13.99 | Sale −$23,685 | 15,333 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Oct 9, 2025 | Oct 14, 2025 | S | 1,800 | $14.02 | Sale −$25,236 | 200,333 | Yes | Form 4 |
| Szot Matthew KChief Financial Officer | Oct 6, 2025 | Oct 7, 2025 | S | 107 | $13.99 | Sale −$1,497 | 17,026 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Oct 2, 2025 | Oct 3, 2025 | S | 500 | $14.13 | Sale −$7,065 | 202,133 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Oct 1, 2025 | Oct 1, 2025 | S | 881 | $14.01 | Sale −$12,343 | 202,633 | Yes | Form 4 |
| Szot Matthew KChief Financial Officer | Oct 1, 2025 | Oct 1, 2025 | S | 1,700 | $13.99 | Sale −$23,783 | 17,133 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Sep 29, 2025 | Oct 1, 2025 | S | 419 | $14.01 | Sale −$5,870 | 203,514 | Yes | Form 4 |
| Szot Matthew KChief Financial Officer | Sep 29, 2025 | Oct 1, 2025 | S | 100 | $14.00 | Sale −$1,400 | 18,833 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Sep 25, 2025 | Sep 26, 2025 | S | 6,790 | $14.09 | Sale −$95,671 | 203,933 | Yes | Form 4 |
| Szot Matthew KChief Financial Officer | Sep 25, 2025 | Sep 26, 2025 | S | 10,900 | $14.05 | Sale −$153,145 | 18,933 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Sep 24, 2025 | Sep 26, 2025 | S | 2,581 | $13.99 | Sale −$36,108 | 210,723 | Yes | Form 4 |
| Szot Matthew KChief Financial Officer | Sep 24, 2025 | Sep 26, 2025 | S | 1,500 | $14.00 | Sale −$21,000 | 29,833 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Aug 28, 2025 | Aug 29, 2025 | S | 1,193 | $13.99 | Sale −$16,690 | 213,304 | Yes | Form 4 |
| Szot Matthew KChief Financial Officer | Aug 28, 2025 | Aug 29, 2025 | S | 400 | $14.00 | Sale −$5,600 | 31,333 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Aug 27, 2025 | Aug 29, 2025 | S | 3,836 | $13.99 | Sale −$53,666 | 214,497 | Yes | Form 4 |
| Szot Matthew KChief Financial Officer | Aug 27, 2025 | Aug 29, 2025 | S | 1,600 | $14.00 | Sale −$22,400 | 31,733 | Yes | Form 4 |
| Pham Quang XCEO and Chairman | Jan 23, 2025 | Mar 24, 20254/A | A · derivative | 65,000 | $19.79 | $1,286,350 | 65,000 | No | Form 4/A |
| Ferguson James J. IIIChief Medical Officer | Feb 5, 2025 | Feb 6, 2025 | A · derivative | 60,000 | $19.75 | $1,185,000 | 60,000 | No | Form 4 |
| Lisicki Robert | Jan 23, 2025 | Jan 24, 2025 | A · derivative | 20,000 | $19.79 | $395,800 | 20,000 | No | Form 4 |
| Szot Matthew KChief Financial Officer | Jan 23, 2025 | Jan 24, 2025 | A · derivative | 50,000 | $19.79 | $989,500 | 50,000 | No | Form 4 |
| Cole Jeffrey ScottChief Operating Officer | Jan 23, 2025 | Jan 24, 2025 | A · derivative | 25,000 | $19.79 | $494,750 | 25,000 | No | Form 4 |
| Zelenkofske Steven | Jan 23, 2025 | Jan 24, 2025 | A · derivative | 20,000 | $19.79 | $395,800 | 20,000 | No | Form 4 |
| Wilson Glynn | Jan 23, 2025 | Jan 24, 2025 | A · derivative | 20,000 | $19.79 | $395,800 | 20,000 | No | Form 4 |
| Murphy John Raymond | Jan 23, 2025 | Jan 24, 2025 | A · derivative | 20,000 | $19.79 | $395,800 | 20,000 | No | Form 4 |
| Pham Quang XCEO and Chairman | Apr 10, 2024 | Apr 10, 2024 | G | 50,000 | $0.00 | $0 | 3,275,000 | No | Form 4 |
| Cole Jeffrey ScottChief Operating Officer | Apr 2, 2024 | Apr 3, 2024 | A · derivative | 150,000 | $0.62 | $93,000 | 150,000 | No | Form 4 |
| Pham Quang XCEO and Chairman | Oct 23, 2023 | Feb 12, 2024 | G | 85,000 | $0.00 | $0 | 3,325,000 | No | Form 4 |
| Losordo Douglas WChief Medical Officer | Jan 18, 2024 | Jan 19, 2024 | A · derivative | 150,000 | $0.94 | $141,000 | 150,000 | No | Form 4 |
| Wilson Glynn | Jan 18, 2024 | Jan 19, 2024 | A · derivative | 70,000 | $0.94 | $65,800 | 70,000 | No | Form 4 |
| Szot Matthew KChief Financial Officer | Jan 18, 2024 | Jan 19, 2024 | A · derivative | 250,000 | $0.94 | $235,000 | 250,000 | No | Form 4 |
| Pham Quang XChief Executive Officer | Jan 18, 2024 | Jan 19, 2024 | A · derivative | 150,000 | $0.94 | $141,000 | 150,000 | No | Form 4 |
| Lisicki Robert | Jan 18, 2024 | Jan 19, 2024 | A · derivative | 50,000 | $0.94 | $47,000 | 50,000 | No | Form 4 |
| Murphy John Raymond | Jan 18, 2024 | Jan 19, 2024 | A · derivative | 100,000 | $0.94 | $94,000 | 100,000 | No | Form 4 |
| Zelenkofske Steven | Jan 18, 2024 | Jan 19, 2024 | A · derivative | 100,000 | $0.94 | $94,000 | 100,000 | No | Form 4 |
| Murphy John Raymond | Oct 5, 2023 | Oct 6, 2023 | P | 2,669 | $0.69 | Purchase +$1,842 | 614,792 | No | Form 4 |
| Murphy John Raymond | Oct 4, 2023 | Oct 6, 2023 | P | 17,331 | $0.70 | Purchase +$12,132 | 612,123 | No | Form 4 |